COVID_Zoom_Banner_1280x200_04


ISSCR COVID-19 Networking Meetings

The ISSCR has launched a new initiative to connect researchers using stem cells to understand SARS-CoV-2 infection and COVID-19 treatment. Every Thursday from 11:00-12:00 EST, the ISSCR hosts a weekly meeting featuring 3-4 scientists that share their latest results, resources, and strategies in this fast-moving area of research. Interested participants should email Covid19@isscr.org for registration information.

Companies interested in sponsoring a COVID-19 Networking Meeting should reach out to Chris Barry, Scientific & Industry Affairs Manager, at cbarry@isscr.org.

Upcoming Meetings

ISSCR COVID-19 Networking Meeting #29 
3 December, 2020
Chairs: Todd McDevitt, PhD & Hans Snoeck, MD, PhD 

  1. SARS-CoV-2 Membrane Fusion Inhibitors - Anne Moscona, MD , Columbia University, USA       
  2. A Molecular Pore Spans the Double Membrane of the Coronavirus Replication Organelle - Montserrat Bárcena, PhD, Leiden University Medical Center, The Netherlands   
  3. Human Lung Stem Cell-Based Alveolospheres Provide Insights Into SARS-CoV-2 Mediated Interferon Responses and Pneumocyte Dysfunction - Purushothama Rao Tata, PhD, Duke University School of Medicine, USA   

Please check back for additional upcoming meeting updates!

Past Meetings

ISSCR COVID-19 Networking Meeting #28 
19 November, 2020
Chairs: Todd McDevitt, PhD & Hans Snoeck, MD, PhD 

  1. Sex Differences in Immune Responses That Underlie COVID-19 Disease Outcomes - Takehiro Takahashi, MD, PhDYale School of Medicine, USA       
  2. Identification of SARS-CoV-2 Inhibitors using Lung and Colonic Organoids - Todd Evans, PhDWeill Cornell Medicine, USA   
  3. Are Human Embryos Vulnerable to SARS-CoV-2 Infection? - Warner Greene, MD, PhDGladstone Institutes & UCSF, USA   

ISSCR COVID-19 Networking Meeting #27 
12 November, 2020
Chairs: Christine Mummery, PhD 

  1. Unexpected Features of Cardiac Pathology in COVID-19 Infection - Richard S. Vander Heide, MD, PhDLSU Health Sciences Center, USA   
  2. Roles of Non-Self-Reactive Antibodies in Protecting the Lung and Cross-Reactive SARS-CoV-2 Antibodies in Neuropathology  - Jakob Kreye, MDGerman Center for Neurodegenerative Diseases, Germany  
  3. Animal Models for SARS-CoV-2 Infection and Vaccine Development - Dan H. Barouch, MD, PhDHarvard Medical School, USA 

ISSCR COVID-19 Networking Meeting #26 
5 November, 2020
Chairs: Todd McDevitt, PhD & Hans Snoeck, MD, PhD 

  1. Global Evaluation of Echocardiography in Patients with COVID-19 - Marc R Dweck, MD, PhDUniversity of Edinburgh, UK
  2. A Single-Cell RNA Expression Map of Human Coronavirus Entry Factors - Cédric Feschotte, PhDCornell University, USA
  3. A Consensus Immunological Signature of COVID-19 Includes Overt Dysregulation of Lympho-/Myelo-Homeostasis - Adrian Hayday, PhDKing’s College London, UK

ISSCR COVID-19 Networking Meeting #25 
29 October, 2020
Chairs: Christine Mummery, PhD & Shuibing Chen, PhD 

  1. Sofosbuvir Protects Human Brain Organoids Against SARS-CoV-2 - Alysson Muotri, PhDUCSD, USA
  2. Toxicity Assessment of Anti-COVID-19 Drugs - Yasunari Kanda, PhD, NIHS, Japan
  3. SARS-CoV-2-Specific T Cell Responses - Shiv Pillai, MD, PhD, MIT and Harvard, USA

ISSCR COVID-19 Networking Meeting #24 
22 October, 2020
Chairs: Todd McDevitt, PhD & Hans Snoeck, MD, PhD 

  1. Inborn Errors of Type I IFN Immunity in Patients With Life-Threatening COVID-19 - Qian Zhang, MDRockefeller University, USA
  2. Auto-Antibodies Against Type I IFNs in Patients With Life-Threatening COVID-19 - Paul Bastard, MDUniversity of Paris, France
  3. Structural Basis of Antibody Responses to SARS-CoV-2 - Ian A. Wilson, PhDScripps Research Institute, USA

ISSCR COVID-19 Networking Meeting #23 
15 October, 2020
Chairs: Christine Mummery, PhD & Shuibing Chen, PhD 

  1. Neuropathology of Patients With COVID-19 in Germany: A Post-Mortem Case Series - Markus Glatzel, MDUniversity Medical Center Hamburg-Eppendorf, Germany
  2. SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2 - Thomas Mandel-Clausen, PhDUCSD, USA
  3. SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses - Abhik Banerjee, MS IICalifornia Institute of Technology, USA

ISSCR COVID-19 Networking Meeting #22 
8 October, 2020
Chairs: Todd McDevitt, PhD & Hans Snoeck, MD, PhD 

  1. Cardiovascular Magnetic Resonance Findings in Competitive Athletes Recovering From COVID-19 Infection - Saurabh Rajpal, MDThe Ohio State University, USA
  2. A Human Pluripotent Stem Cell Model of SARS-CoV-2 Cardiomyocyte Infection - Charles Murry, MD, PhDUniversity of Washington, USA
  3. Direct exposure to SARS-CoV-2 and cigarette smoke increases infection severity and alters the stem cell-derived airway repair response - Brigitte Gomperts, MDUCLA, USA

ISSCR COVID-19 Networking Meeting #21 
1 October, 2020
Chairs: Christine Mummery, PhD & Shuibing Chen, PhD 

  1. COVID-19 Modeling in 3D Human Brain Organoids - Jay Gopalakrishnan, PhDUniversity Hospital Dusseldorf, Germany
  2. Deep Immune Profiling of COVID-19 Patients Reveals Distinct Immunotypes With Therapeutic Implications - John Wherry, PhDUniversity of Pennsylvania, USA
  3. COVID-19 Severity Correlates With Airway Epithelium–Immune Cell Interactions Identified by Single-Cell Analysis - Roland Eils, PhDHumboldt-Universität zu Berlin and Berlin Institute of Health (BIH), Germany

ISSCR COVID-19 Networking Meeting #20 
24 September, 2020
Chairs: Todd McDevitt, PhD & Li Qian, PhD 

  1. Neuroinvasion of SARS-CoV-2 in Human and Mouse Brain - Eric SongYale School of Medicine, USA
  2. The SARS-CoV-2 3A Ion Channel: Structure, Function, and Potential for Drug Targeting - Steve Brohawn, PhDUC Berkeley, USA
  3. Discovery of SARS-CoV-2 Antiviral Drugs Through Large-Scale Compound Repurposing - Sumit Chanda, PhDSanford Burnham Prebys Medical Discovery Institute, USA

ISSCR COVID-19 Networking Meeting #19 
17 September, 2020
Chairs: Christine Mummery, PhD & Shuibing Chen, PhD 

  1. SARS-CoV-2 Infection of Human iPSC-Derived Cardiac Cells Predicts Novel Cytopathic Features in Hearts of COVID-19 Patients - Serah Kang, PhDUCSF & Gladstone Institutes, USA 
  2. Establishing Confidence for Comparing Data - Anne L. Plant, PhDNIST, USA
  3. An Introduction to the Allen Cell Collection and Associated Tools For SARS-CoV-2 Research - Ruwanthi Gunawardane, PhDAllen Institute for Cell Science, USA
  4. Intestinal Organoid Models to Study SARS-CoV-2 Infection and Intrinsic Innate Immune Response - Steeve Boulant, PhDHeidelberg University, Germany

ISSCR COVID-19 Networking Meeting #18 
10 September, 2020
Chairs: Todd McDevitt, PhD & Li Qian, PhD

  1. Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19  - Marcus Buggert, PhDKarolinska Institutet, Sweden 
  2. Systems Biological Assessment of Immunity to Mild Versus Severe COVID-19 Infection in Humans - Bali Pulendran, PhDStanford University, USA
  3. A Human Pluripotent Stem Cell-Derived Brain Organoid Model of SARS-CoV-2 Infection - Jenny Hsieh, PhDUniversity of Texas at San Antonio, USA

ISSCR COVID-19 Networking Meeting #17 
3 September, 2020
Chairs: Christine Mummery, PhD & Shuibing Chen, PhD

  1. Molecular Architecture of the SARS-CoV-2 Virus  - Sai Li, PhDTsinghua University, China
  2. Engineering Human ACE2 to Optimize Binding to the Spike Protein of SARS-CoV-2 - Erik Procko, PhD, University of Illinois at Urbana-Champaign, USA 
  3. Modeling COVID-19 with the Human Airway Lung-Chip - Amy Ryan (Firth), PhDUniversity of Southern California, USA
  4. Drug Repurposing Approaches to Fast Track Development of New Therapies for COVID-19 - Ole Pless, PhD, Fraunhofer Institute for Molecular Biology and Applied Ecology, Germany

ISSCR COVID-19 Networking Meeting #16 
27 August, 2020
Chairs: Todd McDevitt, PhD & Li Qian, PhD

  1. Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases  - Dirk Westermann, MD, PhDUniversity Medical Center Hamburg, Germany
  2. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From COVID-19 - Jedrzej Hoffmann, MDUniversity Hospital Frankfurt, Germany 
  3. Potent Neutralizing Antibodies from COVID-19 Patients Define Multiple Targets of Vulnerability - Marit J. van Gils, PhDAmsterdam UMC, the Netherlands

ISSCR COVID-19 Networking Meeting #15 
20 August, 2020
Chair: Shuibing Chen, PhD

  1. Susceptibility of hPSC-Derived Neural Lineages to SARS-CoV-2 - Lorenz Studer, MD, Memorial Sloan-Kettering Cancer Center, USA
  2. Neuroinvasive Potential of SARS-CoV-2 Revealed in a Human Brain Organoid Model - Eric SongYale School of Medicine, USA
  3. COVID-19 is Marked by a Dysregulated Myeloid Cell Compartment - Joachim L. Schultze, MDUniversity of Bonn, Germany
  4. Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19 - Eric Solary, MD, INSERM & Université Paris-Saclay, France

ISSCR COVID-19 Networking Meeting #14 
13 August, 2020
Chairs: Todd McDevitt, PhD and Li Qian, PhD

  1. Genomic Determinants of Pathogenicity in SARS-CoV-2 and Other Human Coronaviruses - Eugene Koonin, PhD, National Institutes of Health, USA
  2. Molecular Signatures of COVID-19 - Jonathan Schisler, PhD,UNC School of Medicine, USA
  3. Human Pluripotent Stem Cell-Derived Neural Cells and Brain Organoids Reveal SARS-CoV-2 Neurotropism - Guo-li Ming, MD, PhDUniversity of Pennsylvania, USA

ISSCR COVID-19 Networking Meeting #13 
6 August, 2020
Chairs: Christine Mummery, PhD and Shuibing Chen, PhD

  1. A single-cell atlas of the peripheral immune response in patients with severe COVID-19 - Catherine A. Blish, PhD, Stanford University, USA
  2. Serological Analysis of New York City COVID19 Convalescent Plasma Donors - Larry Luchsinger, PhDNew York Blood Center, USA
  3. The UCSC SARS-CoV-2 Genome Browser - Maximilian Haeussler, PhDUC Santa Cruz, USA 
  4. SARS-CoV-2 infection and replication in human fetal and pediatric gastric organoids - Giovanni Giobbe, PhDUniversity College London, UK 

ISSCR COVID-19 Networking Meeting #12 
30 July, 2020
Chairs: Todd McDevitt, PhD and Li Qian, PhD

  1. Pulmonary Alveolar Regeneration in Adult COVID-19 Patients - Nan Tang, PhD, National Institute of Biological Sciences, China
  2. Kinase Inhibitor Screen to Protect Stem Cells in the Lungs from SARS-CoV-2 - Justin Ichida, PhDUniversity of Southern California, USA
  3. SARS-CoV-2 Infection of Pluripotent Stem Cell-Derived Human Lung Alveaolar Type 2 Cells Elicits a Rapid Epithelial-Intrinsic Inflammatory Response - Darrell Kotton, MDCenter for Regenerative Medicine (CReM) of Boston University, USA 

ISSCR COVID-19 Networking Meeting #11 
23 July, 2020
Chairs: Christine Mummery, PhD and Shuibing Chen, PhD

  1. Genomewide Association Study of Severe COVID-19 with Respiratory Failure - Tom H. Karlsen, MD, PhD, University of Oslo, Norway
  2. Therapies for Vascular Stability: Utilizing Computer Designed Proteins to Stabilize Blood Vessels - Hannele Ruohola-Baker, PhDUniversity of Washington, USA
  3. SARS-CoV-2 Infection of Primary Human Lung Epithelium for COVID-19 Modeling and Drug Discovery - Apoorva Mulay, PhDCedars-Sinai, USA
  4. Database and Analytic Strategies to Combat the Cytokine Storm and Develop Treatments for COVID-19 - David C. Fajgenbaum, MD, MBA, MScUniversity of Pennsylvania, USA

ISSCR COVID-19 Networking Meeting #10
16 July, 2020
Chairs: Pamela Robey, PhD and Li Qian, PhD

  1. The Emerging Spectrum of COVID-19 Neurology - Hadi Manji, MD, FRCP, University College London, UK
  2. COVID ‐19: A Global Threat to the Nervous System - Kenneth L. Tyler, MD, University of Colorado School of Medicine, USA
  3. Infectability of Human Neurons and Neurotropism of SARS-CoV-2 - Thomas Hartung, MD, Johns Hopkins Bloomberg School of Public Health, USA

ISSCR COVID-19 Networking Meeting #9
9 July, 2020
Chairs: Christine Mummery, PhD and Shuibing Chen, PhD

  1. Therapeutic Muscle Stem Cell Targeting for the Treatment of COVID-19 Associated Diaphragm Atrophy - Helen Blau, PhD, Stanford University, USA 
  2. COVID-19 Pathogenesis and Associated Thrombosis - Barry Rockx, PhDErasmus MC, Netherlands
  3. Modeling SARS-CoV-2 Infection in Human Brain Organoids - Madeline Lancaster, PhDMRC Laboratory of Molecular Biology, UK
  4. Genome-Wide CRISPR Screen Reveals Host Genes That Regulate SARS-CoV-2 Infection - Craig Wilen, MD, PhDYale University, USA


ISSCR COVID-19 Networking Meeting #8
2 July, 2020
Chairs: Chuck Murry, MD, PhD and Pamela Robey, PhD

  1. Antibody Responses From COVID-19 Survivors - David Koelle, MD, University of Washington, USA
  2. The Cytokine Storm and Multisystem Failure - Mark Wurfel, MD, PhD, UW Medicine, USA
  3. Paediatric Multi System Inflammatory Syndrome Temporally Associated With SARS-CoV-2 - Elizabeth Whittaker, MD, PhD, Imperial College of London, UK

 

ISSCR COVID-19 Networking Meeting #7
18 June, 2020
Chair: Christine Mummery, PhD

  1. Infection of Bat and Human Intestinal Organoids by SARS-CoV-2 - Jane Zhou, PhD, The University of Hong Kong, China
  2. Organoids to study SARS-CoV-2 function and treatment - Ryan Conder, PhD, StemCell Technologies, Canada
  3. A data-driven single-cell analysis of patients with COVID-19 identifies a novel modulator of hyperinflammation - Antonio del Sol, PhD, University of Luxembourg, Luxembourg
  4. Androgen Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men - Faranak Fattahi, PhD, UCSF, USA


ISSCR COVID-19 Networking Meeting #6
11 June, 2020
Chairs: Chuck Murry, MD, PhD and Pamela Robey, PhD

  1. Overview of MSCs: What They Are and Are Not - Pamela Robey, PhD, NIH, USA
  2. MSC-based cell therapies for ARDS - Daniel Weiss, MD, PhD, University of Vermont, USA
  3. Clinical Trials of MSCs for COVID-19 - Silviu Itescu, MBBS, FRACP, Mesoblast, USA & Australia


ISSCR COVID-19 Networking Meeting #5
4 June, 2020
Chairs: Christine Mummery, PhD and Shuibing Chen, PhD

  1. Cloning SARS-CoV-2 Genes - Pei-Hui Wang, PhD, Shandong University, China
  2. Organ-on-a-Chip Model of COVID-19 Thrombosis - Andries van der Meer, PhD, University of Twente, the Netherlands
  3. Bronchial Organoids for SARS-CoV-2 Research - Kazuo Takayama, PhD, CiRA, Japan
  4. HSC-Derived Dendritic Cells for SARS-CoV-2 Vaccine Development - Gay Crooks, MD, UCLA, USA

 

ISSCR COVID-19 Networking Meeting #4
28 May, 2020
Chairs: Chuck Murry, MD, PhD and Pamela Robey, PhD

  1. SARSV-CoV-2 Virology - Michael Gale, PhD, University of Washington, USA
  2. Lung Pathology of COVID-19 - Dan Chertow, MD, MPH, NIH, USA
  3. Modeling COVID-19 with Stem Cell-Derived Lung Organoids - Hans-Willem Snoeck, MD, PhD, Columbia University Medical Center, USA


ISSCR COVID-19 Networking Meeting #3
21 May, 2020
Chairs: Christine Mummery, PhD and Shuibing Chen, PhD

  1. SARS-CoV-2 Pseudovirus - Derya Unutmaz, MD, The Jackson Laboratory, USA
  2. Modeling COVID-19 and the Liver - Robert Schwartz, MD, PhD, Weill Cornell Medical College
  3. Redirecting Research Lines to Address COVID19 - Lygia da Veiga Pereira, PhD, Universidade de São Paulo, Brazil
  4. iPSC-CMs and SARS-CoV-2 Infections - Arun Sharma, PhD, Cedars-Sinai Medical Center, USA

 

ISSCR COVID-19 Networking Meeting #2
14 May, 2020
Chairs: Chuck Murry, MD, PhD and Pamela Robey, PhD

  1. Humanized Mouse Models for COVID-19 Research - Nadia Rosenthal, PhD, The Jackson Laboratory, USA
  2. Pathology of COVID-19 - Desiree Marshall, MD, University of Washington
  3. COVID-19 and the Heart - Eduardo Marbán, MD, PhD, Cedars-Sinai, USA


ISSCR COVID-19 Networking Meeting #1
8 May, 2020
Chairs: Christine Mummery, PhD and Shuibing Chen, PhD

  1. Stem cells and COVID-19 - George Daley, MD, PhD, Harvard Medical School, USA
  2. Stem cell-derived gut organoids and their applications to COVID-19 - Hans Clevers, MD, PhD, Hubrecht Institute, Netherlands
  3. Virology of SARS-CoV-2 - Benjamin R tenOever, PhD, Mount Sinai, USA
  4. Stem cell-derived lung cell applications - Shuibing Chen, PhD, Weill Cornell Medical College, USA
  5. Stem cell-derived cardiac microtissue - Todd McDevitt, PhD, Gladstone Institutes, USA
  6. Vasculature and COVID-19 - Valeria Orlova, PhD, Leiden University Medical Center, Netherlands